Effect of 2,3-dimercaptosuccinic acid on nephrosclerosis in the Dahl rat. I. Role of reactive oxygen species

Kidney International

Volumn 50, Issue 5, 1996, Pages 1572-1581

  Gonick, Harvey C ^a   Cohen, Arthur H ^b   Ren, Qing ^b   Saldanha, Leopoldo F ^b   Khalil Manesh, Farhad ^b   Anzalone, Joseph ^b   Sun, Yan Yu ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; MALONALDEHYDE; OXYGEN RADICAL; SUCCIMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; NEPHROSCLEROSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; ULTRASTRUCTURE;

EID: 0029856142     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.473     Document Type: Article

References (56)

1. PERERA GA: Hypertensive vascular disease: Description and natural history. J Chronic Dis 1:33-42, 1955
2. SOMMERS S, MELAMED J: Renal pathology of essential hypertension. Am J Hypertens 3:583-587, 1990
3. TRACY R, GUZMAN M, OALMANN M, NEWMAN W III, STRONG J: Nephrosclerosis in three cohorts of black and white men born 1925 to 1944, 1934 to 1953 and 1943 to 1962. Am J Hypertens 6:185-192, 1993
4. RUILOPE L, ALCAZAR J, HERNANDEZ E, MORENO F, MARTINEZ M, RODICIO J: Does an adequate control of blood pressure protect the kidney in essential hypertension? J Hypertens 8:525-531, 1990
5. ZUCCHELLI P, ZUCCALA A: The diagnostic dilemma of hypertensive nephrosclerosis: The nephrologist's view. Am J Kid Dis 21:87-91, 1993
6. MEYRIER A, ELADARI D, MONTSENY J, SIMON P, KLEINKNECHT D: Nephrosclerosis in the White: No correlation between hypertension and renal histologic lesions. (abstract) J Am Soc Neph 6:396, 1995
7. HIRAWA N, UEHARA Y, KAWABATA Y, OHSHIMA N, ONO H, NAGATA T, GOMI T, IKEDA T, ATSUO G, YAGI S, OMATA M: Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats. J Hypertens 12:909-918, 1994
8. LEFER A, LEFER D: Endothelial dysfunction in myocardial ischemia and reperfusion: Role of oxygen-derived free radicals. Basic Res Cardiol 86:S109-S116, 1991
9. KONTOS H, WEI E: Endothelium-dependent responses after experimental brain injury. J Neurotrauma 9:349-354, 1992
10. GRYGLEWSKI RJ, PALMER RMJ, MONCADA S: Superoxide anion is involved in the breakdown of endothelium-derived relaxing factor. Nature 20:454-456, 1986
11. WESTLIN W, MULLANE K: Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals? Circulation 77:S30-S39, 1988
12. OHISHI A, SUZUKI H, NAKAMOTO H, KATSUMATA H, SAKAGUCHI H, SARUTA T: Differences in the effects of angiotensin converting enzyme inhibitors with or without a thiol group in chronic renal failure in rats. Clin Sci 76:353-356, 1989
13. UEHARA Y, KAWABATA Y, SHIRAHASE H, WADA K, HASHIZUME Y, MORISHITA S, NUMABE A, IWAI J, MATSUOKA H, SUGIMOTO T: Radical scavenging properties of indapamide and renal protection in Dahl salt-sensitive rats. Hypertens Res 15:17-26, 1992
14. UEHARA Y, NUMABE A, HIRAWA N, KAWABATA Y, IWAI J, ONO H, MATSUOKA H, TAKABATAKE Y, YAGI S, SUGIMOTO T: Antihypertensivc effects of cicletanine and renal protection in Dahl salt-sensitive rats. J Hypertens 9:719-728, 1991
15. UEHARA Y, KAWABATA Y, HIRAWA N, TAKADA S, NAGATA T, NUMABE A, IWAI J, SUGIMOTO T: Possible radical scavenging properties of cicletanine and renal protection in Dahl salt-sensitive rats. Am J Hypertens 6:463-472, 1993
16. KHALIL-MANESH F, GONICK H, WEILER E, PRINS B, WEBER M, PURDY R, REN Q: Effect of chelation treatment with dimercaptosuccinic acid (DMSA) on lead-related blood pressure changes. Environ Res 65:86-99, 1994
17. KHALIL-MANESH F, GONICK H, COHEN A, BERGAMASCHI E, MUTTI A: Experimental model of lead nephropathy. II. Effect of removal from lead exposure and chelation treatment with dimercaptosuccinic acid (DMSA). Environ Res 58:35-54, 1992
18. SHAINKIN-KESTENBAUM R, ADLER A, BERLYNE G: Inhibition of superoxide dismutase activity by silicon. J Trace Elem Electrol Health Dis 4:97-99, 1990
19. DAHL L, HEINE M, TASSINARI L: Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature 194:480-482, 1962
20. COHEN A, BORDER W, RAJFER J, DUMKE A, GLASSOCK R: Interstitial Tamm-Horsfall protein in rejecting renal allografts: Identification and morphologic pattern of injury. Lab Invest 50:515-525, 1984
21. HADDAD I, PATAKI G, HU P, GALLIANI C, BECKMAN JS, MATALON S: Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 94:2407-2413, 1994
22. BECKMAN J, YE Y, ANDERSON P: Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler 375:81-88, 1994
23. RAIJ L, AZAR S, KEANE W: Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 26:137-143, 1984
24. ROSEN S, GREENFELD Z, BERNHEIM J, RATHAUS M, PODJARNY E, BREZIS M: Hypercalcemic nephropathy: Chronic disease with predominant medullary inner stripe injury. Kidney Int 37:1067-1075, 1990
25. ERLER B, CHIEN K, MARCHEVSKY A: An Image Analysis workstation for the pathology laboratory. Modern Pathol 6:612-618, 1993
26. DRAPER H, SQUIRES E, MAHMOODI H: A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radical Biol Med 15:353-363, 1993
27. INDRAPRASIT S, ALEXANDER G, GONICK H: Tissue composition of major and trace elements in uremia and hypertension. J Chronic Dis 27:136-161, 1972
28. DRAPER H, HADLEY M: Malondialdehyde determination as index of lipid peroxidation. Meth Enzymol 186:421-431, 1990
29. RAPP J: Dahl salt-susceptible and salt-resistant rats. Hypertension 4:753-763, 1982
30. RAIJ L, AZAR S, KEANE W: Role of hypertension in progressive glomerular immune injury. Hypertension 7:398-404, 1985
31. MCDONNELL M, KASISKE L, KEANE W: Risk factors for glomerular injury in rats with genetic hypertension. Am J Hypertens 2:9-13, 1989
32. LUCKHAUS G, GARTHOFF B, KAZDA S: Prevention of hypertensive vasculopathy by nifedipine in salt-loaded Dahl rats. Drug Res 32:1421-1425, 1982
33. SHIRAHASE H, UEHARA Y, WADA K, SHIMAJI H, ISHIMITSU T, HASHIZUME Y, KANDA M, NAKAMURA S: Protective effect of the calcium antagonist NKY-722 against renal and arterial injuries in Dahl salt-sensitive rats. J Hypertens 12:137-144, 1994
34. SCHWARTZ G, STRONG C: Renal parenchymal involvement in essential hypertension. Med Clin N Am 71:843-858, 1987
35. SIMONS J, PROVOST A, ANDERSON S, RENNKE H, TROY J, BRENNER B: Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury. Kidney Int 46:396-404, 1994
36. ZATZ R, FUJIHARA C: Glomerular hypertrophy and progressive glomerulopathy: Is there a definite pathogenic correlation? Kidney Int 45(Suppl 45):S27-S29, 1994
37. JACOBSON H: Chronic renal failure: Pathophysiology. Lancet 338:419-423, 1991
38. STRIKER L, PETEN E, ELLIOT S, DOI T, STRIKER G: Biology of disease: Mesangial cell turnover: Effect of heparin and peptide growth factors. Lab Invest 64:446-456, 1991
39. AZAR S, LIMA Z, IWAI J, WELLER D: Single nephron dynamics during high sodium intake and early hypertension in Dahl Rats. Jpn Heart J 20:S138-S140, 1979
40. SHAH S: Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 35:1093-1106, 1989
41. UEHARA Y, NUMABE A, KAWABATA Y, NAGATA T, IWAI J, MATSUOKA H, YAGI S, TAKABATAKE Y, SUGIMOTO T: Evidence for medial-mass regression in the vascular wall of Dahl hypertensive rats by cicletanine treatment. J Cardiovasc Pharmacol 18:158-166, 1991
42. TAGUMA Y, KITAMOTO Y, FUTAKI G, UEDA H, MONMA H, ISHIZAKI M, TAKAHASHI H, SEKINO H, SASAKI Y: Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 313:1617-1620, 1985
43. COOKE JP, STAMLER J, ANDON N, DAVIES PF, MCKINLEY G, LOSCALZO J: Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol 259:H804-H812, 1990
44. MEYERS PR, MINOR RL JR, BATES JN, HARRISON DG: Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrocysteine than nitric oxide. Nature 345:161-163, 1990
45. LAHERA V, KHRAIBI AA, ROMERO JC: Sulfhydryl groups potentiate the hypotensive effect of acetycholine in rats. Hypertension 22:156-160, 1993
46. SEIDEL C, STRONG R: Metabolic characteristics of aorta from spontaneously hypertensive and renal and deoxycorticosterone acetate-salt hypertensive rats. Hypertension 8:103-108, 1986
47. SHARMA R, CRAWFORD D, KRAMSCH D, SEVANIAN A, JIAO Q: Immunolocalization of native antioxidant scavenger enzymes in early hypertensive and atherosclerotic arteries. Role of oxygen free radicals. Arteriosclerosis Thromb 12:403-415 1992
48. KAGAN H, MILBURY P, KRAMSCH D: A possible role for elastin ligands in the proteolytic degradation of arterial elastic lamellae in the rabbit. Cir Res 44:95-103, 1979
49. FREEMAN B, CRAPO J: Free radicals in tissue injury. Lab Invest 47:412-426, 1982
50. SUGAWARA E, NAKAMURA K, MIYAKE T, FUKUMURA A, SAKI Y: Lipid peroxidation and concentration of glutathione in erythrocytes from workers exposed to lead. Br J Ind Med 48:239-242, 1991
51. NAKAZONO K, WATANABE N, MATSUNO K, SASAKI J, SATO T, INQUE M: Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA 88:10045-10048, 1991
52. AUCH-SXHWELK W, KATUSIC Z, VANHOUTTE P: Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension 13:859-964, 1989
53. RADI R, BECKMAN J, BUSH K, FREEMAN BA: Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288:484-487, 1991
54. LANDS W: Interactions of lipid hydroperoxides with cicosanoid biosynthesis. J Free Radicals Biol Med 1:97-101, 1985
55. UEHARA Y, ISHIMITSU T, ISHII M, SUGIMOTO T: Regulatory effects of prostaglandins on thymidine uptake by vascular smooth muscle cells of rats. Prostaglandins 36:847-858, 1988
56. UEHARA Y, NUMABE A, KAWABATA Y, NAGATA T, HIRAWA N, ISHIMITSU T, MATSUOKA H, IKEDA T, SUGIMOTO T: Rapid smooth muscle cell growth and endogenous prostaglandin system in spontaneously hypertensive rats. Am J Hypertens 4:806-814 1991